Robotic Minimally Invasive Benign Hysterectomy Post-market Clinical Study With the DEXTER Robotic System
NCT: NCT07746531 · NOT_YET_RECRUITING
Brief Summary
The purpose of this post-market, observational study is to collect real-world data under anticipated conditions of use that demonstrates that the device performs as intended (accurate, precise control of surgical instruments) in patients undergoing robotic-assisted and laparoscopic hysterectomy for benign disease.
Frequently Asked Questions
What is Robotic Minimally Invasive Benign Hysterectomy Post-market Clinical Study With the DEXTER Robotic System?
Robotic Minimally Invasive Benign Hysterectomy Post-market Clinical Study With the DEXTER Robotic System is a clinical trial registered under NCT07746531. Current status: NOT_YET_RECRUITING.
What is the status of NCT07746531?
The current status of NCT07746531 (Robotic Minimally Invasive Benign Hysterectomy Post-market Clinical Study With the DEXTER Robotic System) is: NOT_YET_RECRUITING.
When did Robotic Minimally Invasive Benign Hysterectomy Post-market Clinical Study With the DEXTER Robotic System start?
Robotic Minimally Invasive Benign Hysterectomy Post-market Clinical Study With the DEXTER Robotic System started on 2026-08-07.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.